Price movement over the last 24 hours
ARPA vs Mira — how do they compare? ARPA trades at Rp159.35 (market cap Rp242,86M, Rp334,7M 24h volume), while Mira trades at Rp779.65 (market cap Rp234,09M, Rp161,43M 24h volume). The key difference: ARPA and Mira are close in size by market cap, and Mira's supply is capped (298M / 1B MIRA (30%)) while ARPA's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold ARPA for 40 Days and Mira for 20 Days on average.
| ARPA | MIRA | |
|---|---|---|
Market Cap | Rp242,86M | Rp234,09M |
Volume (24h) | Rp334,7M | Rp161,43M |
Circulating Supply | 1,5B ARPA | 298M / 1B MIRA (30%) |
Typical Hold Time | 40 Days | 20 Days |
Signals from Pluang's Aura AI — not financial advice
ARPA is trading at Rp155.55 with a market cap of Rp237.75 million, showing mixed technical signals—bearish moving averages but bullish oscillators. The price hovers near the pivot point of Rp159, with support at Rp148 and resistance at Rp165. No major protocol updates or ecosystem developments were noted recently. Trading volume and network activity remain modest, with a hold time of 40 days indicating moderate investor retention.
Overall outlook is cautious due to conflicting indicators and limited fundamental catalysts. Key opportunities include potential rebounds from support levels, while risks involve low liquidity and bearish trend pressure. Investors should monitor for any ecosystem updates or volume spikes that could shift momentum.
MIRA token currently trades at Rp781.29 with a market cap of Rp232.33M, showing bearish technical signals with moving averages indicating strong selling pressure while oscillators remain neutral. The token faces resistance at Rp880 and finds support at Rp770. With only 30% of the 1M max supply in circulation and an average hold time of 20 days, the token shows moderate distribution but limited network activity. Recent news suggests confusion with a pharmaceutical company of similar name, creating potential market noise.
Overall outlook remains cautious with bearish technicals outweighing neutral oscillators. Key opportunities include potential protocol developments if the token gains utility, while major risks involve low liquidity, limited adoption metrics, and identity confusion with unrelated corporate entities. Investors should monitor for genuine crypto project updates rather than pharmaceutical news.
What Pluang investors did over the last 30 days
ARPA Network (ARPA) is a decentralized secure computation network built to improve the fairness, security, and privacy of blockchains. ARPA threshold BLS signature network serves as the infrastructure of verifiable Random Number Generator (RNG), secure wallet, cross-chain bridge and decentralized custody across multiple blockchains. ARPA was previously known as ARPA Chain, a privacy-preserving Multi-party Computation (MPC) network founded in 2018. ARPA Mainnet has completed over 224,000 computation tasks in the past years.
Read more on ARPA →Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →